Accelerating Drug Discovery Through Agentic AI: A Multi-Agent Approach to Laboratory Automation in the DMTA Cycle

• URL: http://arxiv.org/abs/2507.09023v1
• Date: Fri, 11 Jul 2025 21:13:13 GMT
• Title: Accelerating Drug Discovery Through Agentic AI: A Multi-Agent Approach to Laboratory Automation in the DMTA Cycle
• Abstract summary: This paper introduces a novel AI framework, Tippy, that transforms laboratory automation through specialized AI agents.<n>Our multi-agent system employs five specialized agents - Supervisor, Molecule, Lab, Analysis, and Report, with Safety Guardrail oversight.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: The pharmaceutical industry faces unprecedented challenges in drug discovery, with traditional approaches struggling to meet modern therapeutic development demands. This paper introduces a novel AI framework, Tippy, that transforms laboratory automation through specialized AI agents operating within the Design-Make-Test-Analyze (DMTA) cycle. Our multi-agent system employs five specialized agents - Supervisor, Molecule, Lab, Analysis, and Report, with Safety Guardrail oversight - each designed to excel in specific phases of the drug discovery pipeline. Tippy represents the first production-ready implementation of specialized AI agents for automating the DMTA cycle, providing a concrete example of how AI can transform laboratory workflows. By leveraging autonomous AI agents that reason, plan, and collaborate, we demonstrate how Tippy accelerates DMTA cycles while maintaining scientific rigor essential for pharmaceutical research. The system shows significant improvements in workflow efficiency, decision-making speed, and cross-disciplinary coordination, offering a new paradigm for AI-assisted drug discovery.

Related papers

• Benchmarking AI Agents for Addressing Scientific Challenges Across Scales [118.2204632627895]
  SciAgentArena is a systematic benchmark for evaluating AI agents in real-world scientific research scenarios.<n>It comprises approximately 200 tasks with stepwise verification and an interactive, agent-agnostic environment for assessing diverse AI agents.<n>We find that current agents can contribute effectively to well-specified data-analysis, particularly when the task structure and evaluation criteria are clear.
  arXiv  Detail & Related papers  (2026-06-10T22:55:30Z)
• Towards a Virtual Neuroscientist: Autonomous Neuroimaging Analysis via Multi-Agent Collaboration [53.772014300855375]
  We introduce NIAgent, a multi-agent system for autonomous end-to-end neuroimaging analysis.<n>Unlike conventional flat tool-calling agents, NIAgent adopts a code-centric execution paradigm.<n>We propose a hierarchical verification framework for autonomous quality control, integrating cohort-level metric screening with agentic visual inspection.
  arXiv  Detail & Related papers  (2026-05-10T06:30:19Z)
• AI Co-Scientist for Ranking: Discovering Novel Search Ranking Models alongside LLM-based AI Agents with Cloud Computing Access [60.37646376282544]
  We present an AI Co-Scientist framework that automates the full search ranking research pipeline.<n>This is the first study in the ranking community to utilize an AI Co-Scientist framework for algorithmic research.
  arXiv  Detail & Related papers  (2026-03-23T09:29:08Z)
• MedSAM-Agent: Empowering Interactive Medical Image Segmentation with Multi-turn Agentic Reinforcement Learning [53.37068897861388]
  MedSAM-Agent is a framework that reformulates interactive segmentation as a multi-step autonomous decision-making process.<n>We develop a two-stage training pipeline that integrates multi-turn, end-to-end outcome verification.<n>Experiments across 6 medical modalities and 21 datasets demonstrate that MedSAM-Agent achieves state-of-the-art performance.
  arXiv  Detail & Related papers  (2026-02-03T09:47:49Z)
• Democratizing Drug Discovery with an Orchestrated, Knowledge-Driven Multi-Agent Team for User-Guided Therapeutic Design [0.0]
  OrchestRA is a human-in-the-loop multi-agent platform that unifies biology, chemistry, and pharmacology.<n>Unlike static code generators, our agents actively execute simulations and reason the results to drive iterative optimization.
  arXiv  Detail & Related papers  (2025-12-25T11:03:04Z)
• Simple Agents Outperform Experts in Biomedical Imaging Workflow Optimization [69.36509281190662]
  Adapting production-level computer vision tools to bespoke scientific datasets is a critical "last mile" bottleneck.<n>We consider using AI agents to automate this manual coding, and focus on the open question of optimal agent design.<n>We demonstrate that a simple agent framework consistently generates adaptation code that outperforms human-expert solutions.
  arXiv  Detail & Related papers  (2025-12-02T18:42:26Z)
• SelfAI: Building a Self-Training AI System with LLM Agents [79.10991818561907]
  SelfAI is a general multi-agent platform that combines a User Agent for translating high-level research objectives into standardized experimental configurations.<n>An Experiment Manager orchestrates parallel, fault-tolerant training across heterogeneous hardware while maintaining a structured knowledge base for continuous feedback.<n>Across regression, computer vision, scientific computing, medical imaging, and drug discovery benchmarks, SelfAI consistently achieves strong performance and reduces redundant trials.
  arXiv  Detail & Related papers  (2025-11-29T09:18:39Z)
• AI Agents in Drug Discovery [1.9777700354742123]
  Agentic AI systems could integrate diverse biomedical data, execute tasks, carry out experiments via robotic platforms, and iteratively refine hypotheses in closed loops.<n>We provide a conceptual and technical overview of agentic AI architectures, ranging from ReAct and Reflection to Supervisor and Swarm systems.<n>We illustrate their applications across key stages of drug discovery, including literature synthesis, toxicity prediction, automated protocol generation, small-molecule synthesis, drug repurposing, and end-to-end decision-making.
  arXiv  Detail & Related papers  (2025-10-31T03:07:14Z)
• Deep Research Agents: A Systematic Examination And Roadmap [79.04813794804377]
  Deep Research (DR) agents are designed to tackle complex, multi-turn informational research tasks.<n>In this paper, we conduct a detailed analysis of the foundational technologies and architectural components that constitute DR agents.
  arXiv  Detail & Related papers  (2025-06-22T16:52:48Z)
• DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery [54.79763887844838]
  Large language models (LLMs) integrated with autonomous agents hold significant potential for advancing scientific discovery through automated reasoning and task execution.<n>We introduce DrugPilot, a LLM-based agent system with a parameterized reasoning architecture designed for end-to-end scientific in drug discovery.<n>DrugPilot significantly outperforms state-of-the-art agents such as ReAct and LoT, achieving task completion rates of 98.0%, 93.5%, and 64.0% for simple, multi-tool, and multi-turn scenarios, respectively.
  arXiv  Detail & Related papers  (2025-05-20T05:18:15Z)
• Accelerating drug discovery with Artificial: a whole-lab orchestration and scheduling system for self-driving labs [0.0]
  Self-driving labs are transforming drug discovery by enabling automated, AI-guided experimentation.<n>But they face challenges in orchestrating complex, integrating diverse instruments and AI models, and managing data efficiently.<n>Artificial addresses these issues with a comprehensive orchestration and scheduling system.<n>It unifies lab operations, automates, and integrates AI-driven decision-making.
  arXiv  Detail & Related papers  (2025-04-01T17:22:50Z)
• PharmAgents: Building a Virtual Pharma with Large Language Model Agents [19.589707628042422]
  We introduce PharmAgents, a virtual pharmaceutical ecosystem driven by multi-agent collaboration.<n>The system integrates explainable, LLM-driven agents equipped with specialized machine learning models and computational tools.<n>It identifies potential therapeutic targets, discovers promising lead compounds, enhances binding affinity and key molecular properties, and performs in silico analyses of toxicity and synthetic feasibility.
  arXiv  Detail & Related papers  (2025-03-28T06:02:53Z)
• Autonomous Microscopy Experiments through Large Language Model Agents [4.241267255764773]
  Large language models (LLMs) are revolutionizing self driving laboratories (SDLs) for materials research.<n>We introduce Artificially Intelligent Lab Assistant (AILA), a framework automating atomic force microscopy through LLM driven agents.<n>We find that state of the art models struggle with basic tasks and coordination scenarios.
  arXiv  Detail & Related papers  (2024-12-18T09:35:28Z)
• Agents for self-driving laboratories applied to quantum computing [2.840384720502993]
  This paper introduces the k-agents framework, designed to support experimentalists in organizing laboratory knowledge and automating experiments with agents.<n>Our framework employs large language model-based agents to encapsulate laboratory knowledge including available laboratory operations and methods for analyzing experiment results.<n>To automate experiments, we introduce execution agents that break multi-step experimental procedures into agent-based state machines, interact with other agents to execute each step and analyze the experiment results.
  arXiv  Detail & Related papers  (2024-12-10T23:30:44Z)
• DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaboration [24.65716292347949]
  DrugAgent is a multi-agent framework that automates machine learning (ML) programming for drug discovery tasks.<n>Our results show that DrugAgent consistently outperforms leading baselines.
  arXiv  Detail & Related papers  (2024-11-24T03:06:59Z)
• EvoAgent: Towards Automatic Multi-Agent Generation via Evolutionary Algorithms [55.77492625524141]
  EvoAgent is a generic method to automatically extend specialized agents to multi-agent systems.<n>We show that EvoAgent can significantly enhance the task-solving capability of LLM-based agents.
  arXiv  Detail & Related papers  (2024-06-20T11:49:23Z)
• CRISPR-GPT: An LLM Agent for Automated Design of Gene-Editing Experiments [51.41735920759667]
  Large Language Models (LLMs) have shown promise in various tasks, but they often lack specific knowledge and struggle to accurately solve biological design problems. In this work, we introduce CRISPR-GPT, an LLM agent augmented with domain knowledge and external tools to automate and enhance the design process of CRISPR-based gene-editing experiments.
  arXiv  Detail & Related papers  (2024-04-27T22:59:17Z)
• Chemist-X: Large Language Model-empowered Agent for Reaction Condition Recommendation in Chemical Synthesis [55.30328162764292]
  Chemist-X is a comprehensive AI agent that automates the reaction condition optimization (RCO) task in chemical synthesis.<n>The agent uses retrieval-augmented generation (RAG) technology and AI-controlled wet-lab experiment executions.<n>Results of our automatic wet-lab experiments, achieved by fully LLM-supervised end-to-end operation with no human in the lope, prove Chemist-X's ability in self-driving laboratories.
  arXiv  Detail & Related papers  (2023-11-16T01:21:33Z)
• ProAgent: From Robotic Process Automation to Agentic Process Automation [87.0555252338361]
  Large Language Models (LLMs) have emerged human-like intelligence. This paper introduces Agentic Process Automation (APA), a groundbreaking automation paradigm using LLM-based agents for advanced automation. We then instantiate ProAgent, an agent designed to craft from human instructions and make intricate decisions by coordinating specialized agents.
  arXiv  Detail & Related papers  (2023-11-02T14:32:16Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.